Open AccessThe efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia
Author(s) -
Hanyu Wang,
Xueting Xiao,
Qirong Xiao,
Yanhong Lu,
Yong Wu
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000020094
Subject(s) - medicine , idarubicin , cytarabine , daunorubicin , adverse effect , gastroenterology , myeloid leukemia , randomized controlled trial , cochrane library , induction chemotherapy , leukemia , chemotherapy